Randomized phase II study of the Induction Chemotherapy with Docetaxel alone vs CDDP+Docetaxel for c-stage IB-II Non-Small Cell Lung Cancer (JCOG 0204-MF)
Phase 2
- Conditions
- pulmonary neoplasm
- Registration Number
- JPRN-C000000032
- Lead Sponsor
- Japan Clinical Oncology Group(JCOG)
- Brief Summary
See the datails via "URL releasing results" above. Also the details can be seen in the JCOG website: http://www.jcog.jp/en/trials/index.html
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Not provided
Exclusion Criteria
(1) Invasion to the first rib or more superior chest wall (2) Metastasis to, or involvement of, mediastinal node (3) Active concomitant malignancy (4)Unstable angina, recent myocardial infarction, heart failure (5)Uncontrolled diabetes or hypertension (6) Pregnant or lactating women (7)Other severe complications (8)Systemic use of corticosteroid
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method